By Tony Fong

NEW YORK (GenomeWeb News) – A Brooklyn, NY-based epigenetics firm has developed a method for identifying a potentially critical DNA nucleotide that only recently was discovered to be in humans and may play a vital role in switching genes on and off and in the development of diseases such as cancer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Five researchers are to share this year's Albany Medical Center Prize for their work on the CRISPR/Cas9 gene-editing tool, the AP reports.

Stat News reports on how white supremacists cope with surprising genetic ancestry testing results.

In Genome Research this week: sex-biased gene expression evolution in malaria mosquitos, method to find ancient selective sweeps, and more.

Iceland has nearly eliminated Down syndrome from its population, CBS News reports.